Home | Business News | CBJ Newsmakers | Tetra Bio-Pharma Announces PPP003 Program Update Following Type B Meeting With U.S. FDA Tetra Bio-Pharma Announces PPP003 Program Update Following Type B Meeting With U.S. FDA RecommendedMedallion Resources Announces Private Placement of Up to CDN$2,000,000 and Debt Settlement of US$650,000Jade Power Announces First Escrow Release and CVR Distribution and Filing of Q1 2023 Interim Financial StatementsFLINT to pay interest on Senior Secured Debentures in kind
